Investment Rating - The investment rating for the company is "Buy" and is maintained [6] Core Insights - The report highlights Alibaba's unique position in the Chinese internet sector, leveraging AI to enhance consumer experiences across various platforms, aiming to create a one-stop solution for user needs [1] - The rapid growth of the Qianwen app, surpassing 100 million monthly active users, indicates significant commercial opportunities as AI is expected to handle 60%-70% of routine tasks in the digital world over the next two years [2] - Alibaba's comprehensive consumer ecosystem, covering various needs such as clothing, food, accommodation, transportation, and entertainment, is expected to strengthen user loyalty and support long-term performance growth [3] Summary by Sections Investment Rating - The target price is set at HKD 175.30 for the Hong Kong stock and USD 180.00 for the US stock, corresponding to 27.5x and 21.9x FY27-28 non-GAAP forecast PE [5][18] User Growth and Engagement - The Qianwen app has achieved over 100 million monthly active users within two months of launch, significantly exceeding management expectations [2] - The app supports over 400 task types, enhancing user engagement across various sectors, including education and healthcare [2] Ecosystem and Market Position - Alibaba has built a robust consumer ecosystem over nearly 30 years, covering essential consumer needs and creating competitive barriers through cross-channel marketing [3] - The introduction of additional transaction subsidies in the Qianwen app has provided a price advantage over competitors in food delivery and flight booking [4] Financial Projections - The non-GAAP net profit forecasts for FY26-28 are maintained at CNY 94 billion, CNY 110 billion, and CNY 138 billion respectively [5][16] - Revenue projections for FY26-28 are CNY 1,030 billion, CNY 1,120 billion, and CNY 1,218 billion, reflecting growth rates of 3.4%, 8.7%, and 8.8% respectively [10][17]

Investment Rating - The investment rating for the company is "Buy" (maintained) [5] Core Insights - The company has demonstrated a robust performance with a 10% growth in offline retail sales for both adult and children's segments in Q4 2025. The e-commerce platform also recorded high double-digit growth despite external disruptions [7] - The company has launched multiple new products and collaborations, enhancing its brand influence through technological innovations and partnerships [7] - The expansion of "super stores" has exceeded expectations, with 126 stores opened by the end of 2025, including 105 large-format stores and 21 children's stores [7] - The company is expected to see a steady increase in net profit, with projections of RMB 1.315 billion, RMB 1.489 billion, and RMB 1.684 billion for 2025, 2026, and 2027 respectively, reflecting year-on-year growth rates of 14.50%, 13.20%, and 13.13% [6][7] Financial Summary - Revenue projections for the company are as follows: RMB 10,073.51 million in 2024, RMB 11,540.03 million in 2025, RMB 13,113.23 million in 2026, and RMB 14,773.90 million in 2027, with corresponding growth rates of 19.59%, 14.56%, 13.63%, and 12.66% [6][8] - The company's return on equity (ROE) is projected to be 12.25% in 2024, 12.75% in 2025, 12.60% in 2026, and 12.47% in 2027 [6][8] - The price-to-earnings (P/E) ratio is expected to decrease from 11.54 in 2023 to 6.59 in 2027, indicating an attractive valuation over time [6]

证券研究报告 | 2026年01月16日 六福集团（00590.HK） 同店进一步加速增长，海外拓展顺利 |  | 公司研究·公司快评 |  | 商贸零售·专业连锁Ⅱ | 投资评级：优于大市（维持）  | | --- | --- | --- | --- | --- | | 证券分析师： | 张峻豪 | 021-60933168 | zhangjh@guosen.com.cn | 执证编码：S0980517070001 | | 证券分析师： | 柳旭 | 0755-81981311 | liuxu1@guosen.com.cn | 执证编码：S0980522120001 | | 证券分析师： | 孙乔容若 | 021-60375463 | sunqiaorongruo@guosen.com.cn | 执证编码：S0980523090004 | 事项： 公司公告：公司发布 2025 年 10-12 月经营数据，整体零售值同比增长 26%，同店销售增长 15%，均环比上 一季度实现加速。 国信零售观点：1）分区域看，全球市场均表现较好：中国香港同店销售增长 15%，中国澳门增长 22%，海 外增长 11%；中 ...

Investment Rating - The investment rating for WuXi AppTec (2268 HK) is maintained at "Buy" with a target price of HKD 82.24 [8][14]. Core Insights - WuXi AppTec is expected to see significant revenue growth in 2025, with revenue, gross profit, net profit, and adjusted net profit projected to increase by over 45%, 70%, 38%, and 65% year-on-year, respectively [1][2]. - The company plans to acquire Dongyao Pharmaceutical for approximately HKD 3.09 billion, which is anticipated to enhance its competitive edge and capacity [5][6]. - The demand for Contract Research, Development, and Manufacturing Organization (CRDMO) services is expected to rise as global Antibody-Drug Conjugate (ADC) pipelines commercialize [1][3]. Revenue and Profit Forecast - Revenue for 2025 is estimated at approximately HKD 59.6 billion, with a gross profit of HKD 21.1 billion and a net profit of HKD 14.7 billion [2][12]. - The gross margin is projected to be around 35.4%, an increase of about 5 percentage points from 2024, indicating strong operational efficiency [2][12]. - Adjusted net profit is expected to grow by over 65% for the year, despite a decline in profit margins in the second half of 2025 due to foreign exchange impacts and rising expense ratios [2][12]. Project Pipeline - The company signed 70 new iCMC projects in 2025, with 22 being molecular projects, contributing to a total of 252 iCMC projects [3]. - WuXi AppTec is expected to lead in the development of new conjugated molecules, with over half of the new projects being innovative types [3]. - The global market share is projected to increase from 21.7% in 2024 to over 24% in 2025 [3]. Capacity Expansion - The company is expanding its production capacity, with existing DP capacity in Wuxi being maintained and expanded in 2025 [4]. - New production facilities in Singapore are expected to be operational by mid-2025, with additional overseas capacity coming online in 2026 [4]. - The acquisition of the Hefei base is expected to enhance peptide development and production capabilities, with an annual capacity exceeding 40 kg [4]. Acquisition of Dongyao - The acquisition of Dongyao Pharmaceutical is expected to strengthen WuXi AppTec's existing competitive position, as Dongyao has significant production capabilities and a strong client base [5][6]. - Dongyao operates two antibody bulk production lines and three independent ADC bulk production workshops, which will complement WuXi AppTec's offerings [5]. Earnings Forecast and Valuation - Adjusted net profit forecasts for 2025, 2026, and 2027 are revised to HKD 15.9 billion, HKD 22.4 billion, and HKD 31.6 billion, respectively, reflecting a CAGR of 39% [6][12]. - The target price is based on a PEG ratio of 1.06x for 2026, aligning with comparable companies in the sector [6][14].

Investment Rating - The investment rating for the company is maintained as "Buy" with a target price of HKD 22.76 [1][10]. Core Insights - The company reported a slight year-on-year decline in overall retail sales for Q4 2025, but the decline has narrowed compared to previous months. The sales performance in October was boosted by the National Day and Mid-Autumn Festival, while November and December saw a weakening due to the consumer environment and warm winter [6][10]. - Management is confident in achieving revenue and profit margin guidance for 2025, expecting revenue to remain flat and profit margins to increase in the high single digits. The upcoming Olympic year in 2026 is anticipated to drive marketing investments and resource allocation, potentially leading to a turning point in sales [6][10]. - The company is actively managing inventory and risks in a complex retail environment, with a healthy inventory-to-sales ratio returning to a range of 4-5 months [9][10]. Financial Performance - Revenue projections for the company are as follows: - 2024: RMB 28,676 million - 2025E: RMB 28,946 million (up 0.94%) - 2026E: RMB 30,023 million (up 3.72%) - 2027E: RMB 31,825 million (up 6.00%) [5][10]. - Net profit attributable to the parent company is projected to be: - 2024: RMB 3,013 million - 2025E: RMB 2,696 million (down 10.52%) - 2026E: RMB 2,769 million (up 2.73%) - 2027E: RMB 3,171 million (up 14.50%) [5][10]. - The company’s EPS (Earnings Per Share) is expected to be: - 2024: RMB 1.17 - 2025E: RMB 1.04 - 2026E: RMB 1.07 - 2027E: RMB 1.23 [5][10]. Channel Performance - In Q4 2025, offline channels (including retail and wholesale) saw a year-on-year decline in sales, while online sales remained flat. The direct sales channel performed better than wholesale, largely due to contributions from outlet stores [7][10]. - The company continues to expand its store network, with a total of 6,091 stores (excluding Li Ning YOUNG) as of Q4 2025, and plans to open more specialty stores in various categories [8][10]. Discount and Inventory Management - Overall discounts in Q4 2025 deepened slightly year-on-year and quarter-on-quarter, with offline discounts averaging around 65% due to increased clearance efforts for winter apparel amid warm weather [9][10]. - The company has effectively managed inventory levels, with the inventory-to-sales ratio returning to a healthy range, indicating good inventory management practices [9][10].

Investment Rating - The report maintains a "Strong Buy" rating for 康耐特光学 (02276.HK) with an updated target price of HKD 67.75, reflecting a potential upside from the current price of HKD 54.65 [4][8]. Core Insights - Meta is planning to double the production capacity of its AI glasses, Ray-Ban, by the end of this year, indicating strong confidence in the smart eyewear market [2]. - The upcoming launch of the 千问 APP by Alibaba is expected to showcase how AI can enhance operational efficiency [2]. - 康耐特光学 is positioned as a leading lens manufacturer and is actively developing its smart eyewear segment, which is anticipated to become a significant growth driver [8]. Financial Summary - Total revenue projections for 康耐特光学 are as follows: - 2024A: HKD 2,061 million - 2025E: HKD 2,347 million - 2026E: HKD 2,835 million - 2027E: HKD 3,380 million - The revenue growth rates are projected at 17.1% for 2024, 13.9% for 2025, 20.8% for 2026, and 19.2% for 2027 [4][9]. - Net profit estimates are: - 2024A: HKD 428 million - 2025E: HKD 564 million - 2026E: HKD 696 million - 2027E: HKD 869 million - Corresponding net profit growth rates are 31.0% for 2024, 31.7% for 2025, 23.3% for 2026, and 25.0% for 2027 [4][9]. - Earnings per share (EPS) are projected to increase from HKD 0.89 in 2024 to HKD 1.81 in 2027 [4][9]. Market Position and Strategy - 康耐特光学 is actively collaborating with leading 3C companies to expand its smart eyewear offerings, which is expected to enhance its market presence and profitability [8]. - The report highlights the integration of AI capabilities in products like the 夸克 AI glasses, which are expected to drive sales through enhanced user experiences [8].

Investment Rating - The report maintains a "Buy" rating for Li Ning [5] Core Insights - Li Ning's Q4 2025 revenue met expectations, with a slight year-on-year decline in overall revenue. Offline channel revenue decreased in the low single digits, while e-commerce revenue remained flat [1] - The children's clothing segment, Li Ning YOUNG, is expected to continue its steady growth, with 1,518 stores by the end of Q4 2025, reflecting a net increase of 50 stores since the beginning of the year. The inventory turnover ratio is projected to be between 4 and 5, indicating a healthy level [2] - For 2025, the company is expected to report a net profit attributable to shareholders of 2.742 billion yuan, a 9% year-on-year decline. Revenue is anticipated to show slight growth [2] - In 2026, the company plans to enhance its marketing efforts and test new store formats, projecting a revenue growth of 6.5% and a net profit increase of 5.8% to 2.901 billion yuan [3] Financial Summary - Revenue for 2025 is estimated at 29.269 billion yuan, with a year-on-year growth rate of 2.1%. The net profit for 2025 is projected at 2.742 billion yuan, reflecting a decline of 9% [4] - The earnings per share (EPS) for 2025 is expected to be 1.06 yuan, with a price-to-earnings (P/E) ratio of 16.6 times [4] - The company’s return on equity (ROE) is projected to be 10.0% in 2025, with a gradual increase to 10.6% by 2027 [4]

Investment Rating - The investment rating for the company is "Outperform the Market" (maintained) [1] Core Views - The company's retail performance showed a low single-digit decline in sales for the fourth quarter ending December 31, 2025, with offline channels experiencing a mid-single-digit decline and e-commerce remaining flat. The total number of sales points in China was 6,091, a net decrease of 41 from the previous quarter [2][3] - The fourth quarter saw a narrowing decline in sales compared to the third quarter, primarily due to a reduction in the decline of offline channels. The inventory turnover ratio improved to 4-5 months, and new product launches were frequent, including the opening of flagship stores and outdoor stores [2][3][5] - The company is expected to benefit from effective cost control and government subsidies, leading to an upward revision of profit forecasts for 2025-2027, with projected net profits of 26.2 billion, 28.0 billion, and 32.9 billion yuan respectively [2][11] Summary by Sections Retail Performance - For the fourth quarter, the company's sales point performance (excluding Li Ning YOUNG) recorded a low single-digit decline year-on-year. The offline channel saw a mid-single-digit decline, while e-commerce remained stable. The total number of sales points decreased by 41 from the previous quarter [2][3] Sales and Discounts - The fourth quarter saw a low single-digit decline in sales, which improved compared to the third quarter. Retail and wholesale channels experienced low and mid-single-digit declines respectively, while e-commerce remained flat. The discount levels deepened slightly, with inventory turnover improving to 4-5 months [4][5] New Products and Store Formats - The company launched a series of new products in the fourth quarter, including innovative running shoes designed for wet weather. Additionally, the company opened its first outdoor specialty store and a flagship "Dragon Store" in Beijing, targeting the middle-class consumer segment [5][11] Financial Forecasts - The company revised its profit forecasts upward, expecting net profits of 26.2 billion, 28.0 billion, and 32.9 billion yuan for 2025, 2026, and 2027 respectively, reflecting a year-on-year change of -13.1%, +7.0%, and +17.3% [11][12]

研究报告 Research Report 15 Jan 2026 李宁 LI NING (2331 HK) 4Q25 营运表现点评：4Q25 流水符合预期，上调 25 年净利率指引 4Q25 Operating Review: GMV in Line with Expectations; 25E Net Profit Margin Guidance Raised [Table_yemei 观点聚焦 1] Investment Focus [Table_Info] 维持优于大市 Maintain OUTPERFORM 评级 优于大市 OUTPERFORM 现价 HK$19.55 目标价 HK$22.30 HTI ESG 0.8-2.2-3.5 E-S-G: 0-5, (Please refer to the Appendix for ESG comments) 市值 HK$50.53bn / US$6.48bn 日交易额 (3 个月均值) US$42.39mn 发行股票数目 2,585mn 自由流通股 (%) 86% 1 年股价最高最低值 HK$20.28-HK$13.96 注：现价 HK$19.55 为 20 ...

Investment Rating - The investment rating for China Resources Land (01109.HK) is "Buy" (maintained) [1] Core Insights - The company reported a strong sales performance at the end of the year, with a total sales amount of 233.6 billion yuan in 2025, a year-on-year decrease of 10.5%, maintaining a top-three ranking in the industry [6] - The company has actively acquired land, with 33 plots purchased in 2025, corresponding to a planned construction area of 3.39 million square meters and a total land price of 91.7 billion yuan [7] - Regular income showed steady growth, with total regular income reaching 51.15 billion yuan in 2025, a year-on-year increase of 6.5% [8] Summary by Sections Sales Performance - In December, the company achieved a sales amount and area growth of 28.1% and 29.1% year-on-year, respectively, with significant contributions from major cities [6] Land Acquisition - The average land acquisition price was 27,024 yuan per square meter, with a land acquisition intensity of 39% [7] Regular Income - The rental income from operational real estate (shopping centers, office buildings, hotels) was 32.94 billion yuan, reflecting a year-on-year increase of 12.8% [8] Financial Summary - The projected net profit for 2025-2027 is 21.71 billion, 24.07 billion, and 26.37 billion yuan, respectively, with corresponding EPS of 3.05, 3.37, and 3.70 yuan [5][9]